3rd Dec 2010 07:00
GW Pharmaceuticals PLC ("GW Pharmaceuticals" or the "Company")
CHANGE OF ADVISER
and
Notification re Schedule 2 paragraph (g) of the AIM Rules
Porton Down, UK, 3 December 2010: GW Pharmaceuticals (AIM: GWP) today announces that it has appointed Peel Hunt Limited as Nominated Adviser and broker to the Company with immediate effect.
The Company also provides notification in accordance with the AIM Rules that Mr James Noble, a non-executive director of the Company, was previously a Director of Axellis Limited ("Axellis") which entered into a creditors' voluntary liquidation on 26 July 2010.
For further information, please contact:
GW Pharmaceuticals PLC | +44 (0)1980 557 000 |
Adam George, Company Secretary | |
Peel Hunt Limited (Nominated Adviser) | +44 (0) 20 7418 8900 |
James Steel Vijay Barathan | |
Financial Dynamics | + 44 (0) 20 7831 3113 |
Ben Atwell / John Dineen |
Related Shares:
GWP.L